IZI Medical

Executive Summary

IZI Medical is a privately held U.S. medical device manufacturer based in Baltimore, Maryland, established in 1991. The company designs and distributes minimally invasive products for interventional radiology, oncology, and spine care, with a focus on improving procedural accuracy and patient outcomes. Its portfolio includes soft tissue biopsy, breast localization, vertebral augmentation, and vertebroplasty solutions. While the company has operated for over three decades, it remains privately held with limited public disclosure on financials or pipeline progress. Nonetheless, its niche focus and established presence in the interventional oncology and spine markets position it as a potential player in the growing minimally invasive device space. As a private entity, IZI Medical’s near-term drivers are not publicly detailed, but potential catalysts could arise from product line extensions, new FDA clearances, or strategic partnerships. The company’s ability to innovate in the competitive interventional radiology market will be key to its growth. Given the lack of publicly available milestones, conviction in near-term upside is moderate. However, if IZI Medical gains regulatory approvals for novel devices or expands into high-growth areas like tumor ablation or embolization, it could attract acquisition interest or strategic investment.

Upcoming Catalysts (preview)

• Q3 2026FDA Clearance for Next-Generation Soft Tissue Biopsy Device60% success
• Q4 2026Expansion into Tumor Ablation Market via Partnership or Internal Development40% success
• TBDStrategic Acquisition by a Larger MedTech Company30% success